Wednesday, January 20, 2027
186 days away
approved Drug Information
- Drug Name
- Foundayo (orforglipron) (CT.gov)
- Application Type
- NDA
- Indication
- Chronic weight management in adults with obesity or overweight
Filing Details
- Company
- Eli Lilly and Company →
- Stock Ticker
- LLY
- SEC CIK
- 0000059478
- Source
- Company IR →
What is a PDUFA Date?
A PDUFA (Prescription Drug User Fee Act) date is the FDA's target deadline to complete review of a drug application. The FDA aims to make an approval decision by this date.
- Standard Review: 10 months from filing acceptance
- Priority Review: 6 months from filing acceptance
- Possible Outcomes: Approval, Complete Response Letter (CRL), or extension
Explore Eli Lilly and Company
View Eli Lilly and Company's full pipeline, approved drugs, and clinical trials.
Data sourced from SEC EDGAR filings. Last updated: 2026-04-20. Report an issue